AJANTA PHARMA
|
The Current P/S Ratio of AJANTA PHARMA is 7.21.
| Share Price | ₹3,148.1 | May 21,2026 |
| Market Cap | ₹39,319.8 Cr | |
| Sales-TTM | ₹5,452.9 Cr | TTM-Consolidated Results |
| Price/Sales | 7.21x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of AJANTA PHARMA
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹39,319.8 Cr] as on May 21,2026
(/) Sales [ ₹5,452.9 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 7.21x ]
Thus, for AJANTA PHARMA , the investors are currently willing to pay '7.21 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of AJANTA PHARMA !
The chart below summarizes the trend in P/S Ratio of AJANTA PHARMA over the last five years.
Historical PS (Price/Sales) ratio chart of AJANTA PHARMA
PS Ratio Performance Analysis for AJANTA PHARMA
- AJANTA PHARMA 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 5.56x.
- AJANTA PHARMA 's operated at median p/e ratio of 5.37x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, AJANTA PHARMA 's p/e ratio peaked in Mar2025 at 7.04x.
- AJANTA PHARMA 's p/e ratio hit its five-year low in Mar2023 of 4.07x.
How does AJANTA PHARMA 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| AJANTA PHARMA | 5,452.9 | 7.21 | 39,319.8 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 56,809.1 | 7.99 | 453,750.0 |
| DIVIS LABORATORIES LTD | 10,314.0 | 17.66 | 182,117.0 |
| TORRENT PHARMACEUTICALS LTD | 12,742.0 | 11.88 | 151,314.0 |
| CIPLA LTD | 28,162.6 | 4.02 | 113,225.0 |
| DR REDDYS LABORATORIES LTD | 33,700.2 | 3.27 | 110,037.0 |
| MANKIND PHARMA LTD | 14,277.6 | 7.27 | 103,845.0 |
| LUPIN LTD | 27,958.0 | 3.74 | 104,490.0 |
| ZYDUS LIFESCIENCES LTD | 27,148.4 | 3.84 | 104,266.0 |
| AUROBINDO PHARMA LTD | 33,181.9 | 2.68 | 88,979.3 |
| LAURUS LABS LTD | 6,812.9 | 10.70 | 72,918.4 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs AJANTA PHARMA 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.68x |
| Max industry PS | 17.66x |
| Median industry PS | 7.21x |
| Average industry PS | 7.30x |
You may also like the below Video Courses